Original article
Clinical endoscopy
Digital single-operator peroral cholangioscopy-guided biopsy sampling versus ERCP-guided brushing for indeterminate biliary strictures: a prospective, randomized, multicenter trial (with video)

https://doi.org/10.1016/j.gie.2019.11.025Get rights and content

Background and Aims

Accurately diagnosing indeterminate biliary strictures is challenging but important for patient prognostication and further management. Biopsy sampling under direct cholangioscopic vision might be superior to standard ERCP techniques such as brushing or biopsy sampling. Our aim was to investigate whether digital single-operator cholangioscopy (DSOC) compared with standard ERCP workup improves the diagnostic yield in patients with indeterminate biliary strictures.

Methods

Patients with an indeterminate biliary stricture on the basis of MRCP were randomized to standard ERCP visualization with tissue brushing (control arm [CA]) or DSOC visualization and DSOC-guided biopsy sampling (study arm [SA]). This was a prospective, international, multicenter trial with a procedure-blinded pathologist.

Results

The first sample sensitivity of DSOC-guided biopsy samples was significantly higher than ERCP-guided brushing (SA 68.2% vs CA 21.4%, P < .01). The sensitivity of visualization (SA 95.5% vs CA 66.7%, P = .02) and overall accuracy (SA 87.1% vs CA 65.5%, P = .05) were significantly higher in the SA compared with the CA, whereas specificity, positive predictive value, and negative predictive value showed no significant difference. Adverse events were equally low in both arms.

Conclusions

DSOC-guided biopsy sampling was shown to be safe and effective with a higher sensitivity compared with standard ERCP techniques in the visual and histopathologic diagnosis of indeterminate biliary strictures. (Clinical trial registration number: NCT 03140007.)

Abbreviations

CA
control arm
DSOC
digital single-operator cholangioscopy
SA
study arm
TPB
transpapillary biopsy sampling and/or brushing

Cited by (0)

DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: C. Gerges: Consultant for Microtech Europe GmbH. T. Beyna: Investigator for Boston Scientific– and Olympus-sponsored trials; consultant and lecture fees from Boston Scientific. J. Y. W. Lau, M. Ramchandani: Investigator for Boston Scientific–sponsored trials. R. Tang: APAC medical advisory board for Boston Scientific. All other authors disclosed no financial relationships. Statistical and database support for this study was provided by Boston Scientific.

See CME section; p. 1187.

If you would like to chat with an author of this article, you may contact Dr Ramchandani at [email protected].

Drs Gerges and Beyna contributed equally to this article.

View Abstract